For Immediate Release: June 12, 2017
513-579-9911 x 12523
Medpace to Present at Medical Device Conference:
“How to leverage expert oversight and management in critical areas to avoid hidden costs in conducting clinical trials”
CINCINNATI, OH — (June 12, 2017) – Medpace (MEDP), a scientifically-driven, global full-service clinical research organization (CRO), announced that Deborah Schmalz, Executive Director of Medpace Medical Device, will be presenting at the upcoming Outsourcing in Clinical Trials: Medical Devices 2017 conference on Tuesday, June 27th at 10:00a.m. PST
About the Presentation
SESSION TITLE: How to leverage expert oversight and management in critical areas to avoid hidden costs in conducting clinical trials
- Trial Design – Too many companies hurry through trial design without critical and collaborative input from medical, regulatory and operational experts. If you don’t invest early, you will likely pay later
- Site Selection – Poor decisions can lead to lengthy start-up, lack-luster recruitment, and quality issues – all leading to time delays and higher costs
- Data management/biometrics/medical writing – Ensure your data is processed expeditiously and reports are generated without delays; if not, it could lead to lost revenue for you
As the Executive Director of Medpace Medical Device, Deborah Schmalz is responsible for the global operations of the medical device group. With 20+ years of experience as an executive in the medical device industry, she has the operational know-how and leadership capabilities to navigate the complexities of device trials.
Medpace Medical Device is a division of Medpace exclusively dedicated to the design and conduct of medical device trials. Medpace Medical Device is headquartered in Minneapolis, Minnesota, and is supported by a European office in Vaals, Netherlands and other locations strategically placed throughout the world. MMD is managed by a team with extensive device industry experience.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries.